FDA.reportPublic FDA data

TALAZOPARIB Pharmacologic Class Indexing

Class set ID
9cf68559-0a6f-47e5-8170-d47dcbb40fcc
Version
1
Effective date
20190110
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 2018U.S. Pharmaceuticals | Pfizer Inc | Pharmacia & Upjohn Company LLC | SGS Institut Fresenius GmbH | Sharp Packaging Services, LLC2026060110
These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 2018Pfizer Laboratories Div Pfizer Inc | Pfizer Ireland Pharmaceuticals Unlimited Company | Eurofins Biolab Srl202604104
These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 2018Pfizer Laboratories Div Pfizer Inc | Viatris Pharmaceuticals LLC | Pharmacia & Upjohn Company LLC2025121819
These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 2018U.S. Pharmaceuticals | Pfizer Inc202407091